Tej Ishaan Mehta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tej Ishaan Mehta has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- Caleb J. Heiberger
Radiology, University of South Dakota Sanford School of Medicine, Sioux Falls, USA
6 shared publications Douglas Yim
Avera Medical Group, Sioux Falls, South Dakota
6 shared publicationsOluwagbenga Serrano
Gastroenterology, Avera McKennan Hospital, University Health Center, Sioux Falls, South Dakota, USA
4 shared publicationsCristina Jensen
3 shared publications- Simcha Weissman
Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA
3 shared publications Christopher Auvenshine
Avera Medical Group Transplant & Liver Surgery, Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota
2 shared publications
Latest Publications
- 1 November 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (6) , e250265
Metastatic Meningioma: Neuroradiologic and Molecular Imaging Perspectives
Metastatic meningioma exhibits diverse dissemination patterns across organ systems (lungs, bone, liver, soft tissue, etc), with molecular imaging—particularly gallium 68 DOTA Tyr3-octreotide PET/CT—playing a pivotal role in detection, characterization, and guiding management.
- 1 November 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (6) , e250265
Metastatic Meningioma: Neuroradiologic and Molecular Imaging Perspectives
Metastatic meningioma exhibits diverse dissemination patterns across organ systems (lungs, bone, liver, soft tissue, etc), with molecular imaging—particularly gallium 68 DOTA Tyr3-octreotide PET/CT—playing a pivotal role in detection, characterization, and guiding management.
- 27 April 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (8) , 1176-1186.e1
Comparison of Outcomes of Drug-Coated Balloons versus Plain Balloons in Secondary Interventions on Percutaneous Arteriovenous Fistulae
- 27 April 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (8) , 1176-1186.e1
Comparison of Outcomes of Drug-Coated Balloons versus Plain Balloons in Secondary Interventions on Percutaneous Arteriovenous Fistulae
- 1 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (4) , 359-367.e8
Minimally Invasive Treatments for Benign Prostatic Hyperplasia: Systematic Review and Network Meta-Analysis
- 1 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (4) , 359-367.e8
Minimally Invasive Treatments for Benign Prostatic Hyperplasia: Systematic Review and Network Meta-Analysis
- Top Cited Papers
- 1 November 2021
- Published by Elsevier in Journal of Hepatology
- Vol. 75 (5) , 1026-1033
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
- 1 November 2021
- Published by Elsevier in Journal of Hepatology
- Vol. 75 (5) , 1026-1033
Top Cited PapersIdentification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
- 19 June 2021
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4) , e13671
Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin
Blastomycosis is a fungal infection caused primarily by Blastomyces dermatitis. The fungus is endemic to the Ohio, Mississippi, and St. Lawrence River areas of the United States. Organ transplant recipients are at risk of blastomycosis due to pharmacologic immunosuppression. Over a 20‐year period, 30 cases of blastomycosis post‐solid organ transplantation were identified at our center. The cumulative incidence of blastomycosis among SOT recipients was 0.99%. There was a male predominance (70% male) and a median age of 59 at the time of diagnosis. Regarding transplant type, 23 patients received kidney transplants, 4 received liver transplants, 2 received pancreas transplants and 1 received a heart transplant. Median time to blastomycosis identification post‐transplant was 67.8 months (range: 1‐188 months). Amphotericin B was used as initiation therapy in most cases, followed by itraconazole, voriconazole, or in select cases fluconazole or posaconazole maintenance therapy. Regarding comorbid conditions, 87% of patients had diabetes, 50% had congestive heart failure, and 20% had chronic pulmonary disease. Nine patients (30%) developed blastomycosis‐related acute respiratory distress syndrome, 33% of these died with a median time to death of 22 days (range 20 days to 2 months); these were the only deaths attributable to blastomycosis.
- 19 June 2021
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4) , e13671
Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin
Blastomycosis is a fungal infection caused primarily by Blastomyces dermatitis. The fungus is endemic to the Ohio, Mississippi, and St. Lawrence River areas of the United States. Organ transplant recipients are at risk of blastomycosis due to pharmacologic immunosuppression. Over a 20‐year period, 30 cases of blastomycosis post‐solid organ transplantation were identified at our center. The cumulative incidence of blastomycosis among SOT recipients was 0.99%. There was a male predominance (70% male) and a median age of 59 at the time of diagnosis. Regarding transplant type, 23 patients received kidney transplants, 4 received liver transplants, 2 received pancreas transplants and 1 received a heart transplant. Median time to blastomycosis identification post‐transplant was 67.8 months (range: 1‐188 months). Amphotericin B was used as initiation therapy in most cases, followed by itraconazole, voriconazole, or in select cases fluconazole or posaconazole maintenance therapy. Regarding comorbid conditions, 87% of patients had diabetes, 50% had congestive heart failure, and 20% had chronic pulmonary disease. Nine patients (30%) developed blastomycosis‐related acute respiratory distress syndrome, 33% of these died with a median time to death of 22 days (range 20 days to 2 months); these were the only deaths attributable to blastomycosis.
- 1 November 2020
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (11) , 1753-1762
Effectiveness of Radiofrequency Ablation in the Treatment of Painful Osseous Metastases: A Correlation Meta-Analysis with Machine Learning Cluster Identification
- 1 November 2020
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (11) , 1753-1762
Effectiveness of Radiofrequency Ablation in the Treatment of Painful Osseous Metastases: A Correlation Meta-Analysis with Machine Learning Cluster Identification
- 1 November 2020
- Published by Elsevier in Transplantation Proceedings
- Vol. 52 (9) , 2790-2794
Early Cardiopulmonary Cryptococcus neoformans Infection After Liver Transplant: A Case Report
- 1 November 2020
- Published by Elsevier in Transplantation Proceedings
- Vol. 52 (9) , 2790-2794
Early Cardiopulmonary Cryptococcus neoformans Infection After Liver Transplant: A Case Report